1 INTRODUCTION
1.1 OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.3 RESEARCH METHODOLOGY
1.3.1 SECONDARY DATA
1.3.2 PRIMARY DATA
1.3.3 MARKET SIZE ESTIMATION
1.3.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.4 STAKEHOLDERS
1.5 CURRENCY
1.6 RESEARCH ASSUMPTIONS
1.7 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 DROC MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 COST STRUCTURE ANALYSIS
3.6 VALUE CHAIN ANALYSIS
3.7 COVID-19 IMPACT ANALYSES
4 INDUSTRY TRENDS
4.1 INTRODUCTION
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES MODEL
4.3.1 DEGREE OF COMPETITION
4.3.2 BARGAINING POWER OF BUYERS
4.3.3 BARGAINING POWER OF SUPPLIERS
4.3.4 THREAT FROM SUBSTITUTES
4.3.5 THREAT FROM NEW ENTRANTS
5 E-PHARMACY TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2015-2019
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 PRESCRIPTION DRUG
5.6 OVER THE COUNTER (OTC) DRUGS
6 E-PHARMACY MARKET PRODUCT TYPE ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET PRODUCT TYPE ANALYSIS, 2015-2019
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 SKIN CARE
6.6 DENTAL
6.7 COLD AND FLU
6.8 VITAMINS
6.9 WEIGHT LOSS
6.10 OTHER
7 E-PHARMACY MARKET OPERATING PLATFORM ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET OPERATING PLATFORM ANALYSIS, 2015-2019
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 DIABETIC FOOT ULCERS
7.6 PRESSURE ULCERS
7.7 SURGICAL AND TRAUMATIC WOUNDS
7.8 BURNS
7.9 OSTOMY CARE
7.10 OTHERS
8 E-PHARMACY MARKET THERAPY AREA ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET THERAPY AREA ANALYSIS, 2015-2019
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 WEIGHT LOSS
8.6 VITAMINS
8.7 COLD & FLU
8.8 DERMATOLOGY
8.9 OTHERS
9 E-PHARMACY MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 HOSPITAL
9.6 CLINIC
10 GLOBAL E-PHARMACY REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 SOUTH AMERICA
10.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 MARKET PLAYERS
11.1 CVS HEALTH CORPORATION
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 RECENT DEVELOPMENTS
11.1.4 SWOT ANALYSIS:
11.2 CIGNA CORPORATION (EXPRESS SCRIPTS HOLDINGS)
11.3 GIANT EAGLE INC.
11.4 THE KROGER CO.
11.5 WALGREEN BOOTS ALLIANCE (WALGREEN CO.)
11.6 AMAZON.COM INC.
11.7 ALBERTSONS COMPANIES INC.
11.8 ALTO
11.9 AXELIA SOLUTIONS (PHARMEASY)
11.10 AZOYA MASTER
11.11 APEX HEALTHCARE BERHAD (APEX PHARMACY)
11.12 FARMAKU
11.13 WALGREEN CO.
11.14 EXPRESS SCRIPTS HOLDING COMPANY
11.15 L ROWLAND & CO RETAIL LTD
11.16 OPTUMRX, INC.
11.17 WALMART STORES, INC.
11.18 PHARMACY2U
11.19 DOCTOR RAKSA CO. LTD
11.20 APOLLO PHARMACY
11.21 THE ONLINE DRUGSTORE
11.22 DOCMORRIS (ZUR ROSE GROUP AG)
11.23 LLOYDSPHARMACY
11.24 NETMEDS.COM
12 ABOUT US

TABLE 1 E-PHARMACY REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 2 GLOBAL E-PHARMACY MARKET, 2020–2030, (USD MILLION)
TABLE 3 E-PHARMACY CURRENT AND FUTURE REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 4 GLOBAL E-PHARMACY HISTORICAL MARKET TYPE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 5 E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 6 GLOBAL E-PHARMACY HISTORICAL MARKET PRODUCT TYPE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 7 E-PHARMACY CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 8 GLOBAL E-PHARMACY HISTORICAL MARKET OPERATING PLATFORM ANALYSIS, 2015-2019, (USD MILLION)
TABLE 9 E-PHARMACY CURRENT AND FUTURE OPERATING PLATFORM ANALYSIS, 2020–2030 (USD MILLION)
TABLE 10 GLOBAL E-PHARMACY HISTORICAL MARKET THERAPY AREA ANALYSIS, 2015-2019, (USD MILLION)
TABLE 11 E-PHARMACY CURRENT AND FUTURE THERAPY AREA ANALYSIS, 2020–2030 (USD MILLION)
TABLE 12 GLOBAL E-PHARMACY HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019, (USD MILLION)
TABLE 13 E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 14 NORTH AMERICA E-PHARMACY HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 15 NORTH AMERICA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 16 NORTH AMERICA E-PHARMACY CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 17 NORTH AMERICA E-PHARMACY CURRENT AND FUTURE OPERATING PLATFORM ANALYSIS, 2020–2030 (USD MILLION)
TABLE 18 NORTH AMERICA E-PHARMACY CURRENT AND FUTURE THERAPY AREA ANALYSIS, 2020–2030 (USD MILLION)
TABLE 19 NORTH AMERICA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 20 U.S. E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2015–2020
TABLE 21 U.S. E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 22 U.S. E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 23 CANADA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 24 CANADA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 25 MEXICO E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 26 MEXICO E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 27 APAC E-PHARMACY HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 28 ASIA-PACIFIC E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC E-PHARMACY CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC E-PHARMACY CURRENT AND FUTURE OPERATING PLATFORM ANALYSIS, 2020–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC E-PHARMACY CURRENT AND FUTURE THERAPY AREA ANALYSIS, 2020–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 33 CHINA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 34 CHINA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 35 JAPAN E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 36 JAPAN E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 37 KOREA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 38 KOREA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 39 INDIA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 40 INDIA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 41 SOUTHEAST ASIA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 42 SOUTHEAST ASIA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA E-PHARMACY HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA E-PHARMACY CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA E-PHARMACY CURRENT AND FUTURE OPERATING PLATFORM ANALYSIS, 2020–2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA E-PHARMACY CURRENT AND FUTURE THERAPY AREA ANALYSIS, 2020–2030 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 49 SAUDI ARABIA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 50 SAUDI ARABIA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 51 UAE E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 52 UAE E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 53 EGYPT E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 54 EGYPT E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 55 NIGERIA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 56 NIGERIA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 57 SOUTH AFRICA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 58 SOUTH AFRICA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 59 EUROPE E-PHARMACY HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 60 EUROPE E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 61 EUROPE E-PHARMACY CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 62 EUROPE E-PHARMACY CURRENT AND FUTURE OPERATING PLATFORM ANALYSIS, 2020–2030 (USD MILLION)
TABLE 63 EUROPE E-PHARMACY CURRENT AND FUTURE THERAPY AREA ANALYSIS, 2020–2030 (USD MILLION)
TABLE 64 EUROPE E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 65 GERMANY E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 66 GERMANY E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 67 FRANCE E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 68 FRANCE E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 69 UK E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 70 UK E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 71 RUSSIA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 72 RUSSIA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 73 ITALY E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 74 ITALY E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 75 SOUTH AMERICA E-PHARMACY HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 76 SOUTH AMERICA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 77 SOUTH AMERICA E-PHARMACY CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 78 SOUTH AMERICA E-PHARMACY CURRENT AND FUTURE OPERATING PLATFORM ANALYSIS, 2020–2030 (USD MILLION)
TABLE 79 TABLE 82 SOUTH AMERICA E-PHARMACY CURRENT AND FUTURE THERAPY AREA ANALYSIS, 2020–2030 (USD MILLION)
TABLE 80 SOUTH AMERICA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 81 BRAZIL E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 82 BRAZIL E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 83 ARGENTINA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 84 ARGENTINA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 85 COLUMBIA E-PHARMACY CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 86 COLUMBIA E-PHARMACY CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)